Skip to content

Integral Remediation for Major Depression (Rehabilitación Integral Para la Depresión Mayor, RIDEM)

RIDEM Integral Remediation for Major Depression. Efficacy Study of a Functional Remediation Program and Cognitive Training

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03624621
Acronym
RIDEM
Enrollment
52
Registered
2018-08-10
Start date
2018-03-15
Completion date
2020-12-31
Last updated
2022-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitive Symptom, Major Depressive Disorder

Keywords

Major Depressive Disorder, Cognitive Remediation, Functioning, Full Recovery, Functional Remediation

Brief summary

Available pharmacological and psychotherapeutic treatments are not effective for the treatment of cognitive symptoms of major depressive disorder (MDD). More recent studies have described that functional disability and the indirect costs of MDD (e.g., sick leaves at work, decreased productivity, ...) are related to persistent cognitive deficits. Some programs of cognitive rehabilitation and cognitive training (developed for other pathologies) have been tested, but the results are inconsistent. There is an imperative need to develop a specific comprehensive rehabilitation program for MDD that includes the benefits of traditional functional remediation (FR) and computerized cognitive training (CCT) programs adjusted for each patient's cognitive deficit.

Detailed description

Objectives: To develop the Integral Rehabilitation Program (FR + CCT) and to demonstrate its efficacy in cognitive and functional remission (i.e. global remission) of patients with MDD in clinical remission. Methodology: The project will consist of two stages: 1. \- Development and adaptation of the Integral Rehabilitation program for MD, based on the program developed for bipolar disorder, and including a computerized cognitive training adjusted to the neuropsychological profile of each patient; 2. \- A clinical trial, randomized, blind evaluator, with three intervention arms: INTEGRAL REHABILITATION (FR + CCT); PSYCHOEDUCATION + online games; and TREATMENT AS USUAL. Sample size will be a total of 90 patients with MDD in remission (full or partial).

Interventions

BEHAVIORALPsychoeducation

12 sessions of psychoeducation on depression, providing information about the disease, causes, consequences and other useful data for the management of depression.

Functional remediation includes directed group sessions tapping into the main cognitive domains affected in depression (executive functioning, attention and memory) as well as their implication in daily living.

12 add-on sessions (20-minute long) after each group session to train cognitive domains.

DEVICEOnline games

Participants play non-directed online games during 20 minutes after each psychoeducation grup session to make the two active intervention more similar.

Sponsors

Instituto de Salud Carlos III
CollaboratorOTHER_GOV
Hospital de Sant Pau
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Codification of participants, assessor will never know what treatment arm participant was allocated

Intervention model description

Randomized single-blind and controlled clinical trial

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* 18 and 60 years (males and females) * diagnosis of Major Depression (criteria Diagnostic and Statistical Manual 5th edition, DSM-5) in Remission or Partial Remission phase (scores below 14 in the Hamilton Depression Rating Scale-17 items (HDRS-17)) * Cognitive Symptoms (-1.5SD (standar deviation) in objective as subjective tests), * PDQ \> 20 * FAST\> 17

Exclusion criteria

* Intelligence Quotient (IQ) \< 85 * Any medical condition that may affect cognition * Presence of any comorbid psychiatric condition (including abuse or dependence on substances in the last three months) * Electroconvulsive therapy (ECT) in the previous year * Other psychological intervention in the 6 months prior to the study.

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline Functioning Assessment Short Test (FAST) score at 6 and 15 months3 and 12 months after interventionAssessment of daily functioning of depressed patients, including economics, cognition, social relationships, leisure and personal care

Secondary

MeasureTime frameDescription
Change from baseline perceived cognitive deficits (PDQ)3 and 12 months after interventionSelf-appraisal of cognitive functioning

Other

MeasureTime frameDescription
Change from baseline cognitive functioningbaseline and 12 months after interventionObjective neuropsychological battery to assess cognitive domains

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 3, 2026